) totaling of 2,583.4 million baht, or 11.3%, mainly due to an increase หน้า 5 ของ 5   of cash and cash equivalents, project development costs for sale and deposits for land which paid in advance for the

Statement of Financial Position as of 31 March 2018 The Company and its subsidiary’s total assets as of 31 March 2018 increased by 9% yoy. The growth was mainly contributed by the increase of cash & temporary

238.81 million as of December 31, 2017 from the significant reasons of the increase of cash, inventory and investment in associates and joint venture. In this regard, cash increased from the issuance of

 to each offshore subsidiary's base currency.  Payout Analysis No dividends were paid in Q118 or Q117. Financial Status The group currently has no interest bearing debt.  Cash reserves and financial

that of Baht 454.20 million as at December 31, 2017, mainly attributable to increases by Baht 67.78 million in cash and cash equivalents, Baht 30.13 million in inventories and Baht 11.52 million in

to an increase in cash of Bt95 million, a small decrease in the value of property, plant and equipment-net (consisting of the acquisition of an additional investment in a new factory of Bt320 million

 of THB 1.00 per share was paid during the quarter from the profits of 2016. Financial Status The group currently has no interest bearing debt.  Cash reserves and financial investments at the 30th June

of Baht 454.20 million as at December 31, 2017, mainly attributable to increases by Baht 957.15 million in cash and cash equivalents which increase form IPO, Baht 18.54 million in บริษัท ดโีอด ีไบโอเทค

developments, and Cash and cash equivalents. As for liabilities, an increase of 2,341.3 million baht, or 14.2%, mainly from long-term debentures, and short and long term loans from banks. These were done as

Baht 7.09 million from the end of the previous year as a result of a decrease in cash and cash equivalent of Baht 29.90 million, temporary investment fund of Baht 84.64 million, account receivable of